![](/img/cover-not-exists.png)
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
Carter, Lawrence P, Henningfield, Jack E, Wang, Y Grace, Lu, Yuan, Kelsh, Debra, Vince, Bradley, Sellers, EdwardLanguage:
english
Journal:
Journal of Psychopharmacology
DOI:
10.1177/0269881118796814
Date:
October, 2018
File:
PDF, 709 KB
english, 2018